Press Office

The rapidly growing pipeline of genetically modified therapies reflects the surge in demand for high quality vectors, presenting lucrative opportunities for companies w... read more
Given the success of approved CAR-T cell therapies, such as KYMRIAH®, YESCARTA®, TECARTUS® and BREYANZI®, this... read more
Advances in information technology and biomedical science have enabled the development of digital solutions for biomarkers, which, owing to the myriad of pe... read more
In modern healthcare, the applications of real world data-based insights are vast, ranging from drug discovery to supporting regulatory decision-making; in fact, t... read more
Driven by the urgent need to address off-target toxicity-related concerns and improve therapeutic outcomes of biologic drugs, several patient-centric medical device... read more
mRNA as a therapeutic / preventive agent has been demonstrated to be well tolerated in vivo, and can harness the cell’s translational machinery to invoke humoral an... read more
The anticipated growth in global diabetic patient population is likely to result in a significant rise in demand for novel, safe and more patient friendly drug ... read more
The anticipated growth in the global diabetic patient population is likely to translate into significant rise in demand for advanced, cost-effective and more patient friendly solutions for disease mo... read more
Besides portability, handheld X-ray scanners offer a wide range of benefits, including cost savings; in the initial days of the pandemic, such devices... read more
Driven by the potential treat the root cause of diseases, including rare clinical conditions and those that were previously deemed incurable, the gene t... read more
Advances in 3D cell culturing, have led to the discovery of better scaffold fabrication techniques and also enabled various parts of the pro... read more
Human factors engineering and usability testing have now become an essential part of product design across almost all industries, offering dev... read more
STING pathway modulation, using appropriate pharmacological interventions, has emerged as a viable approach to harnessing ... read more
Growing awareness of the impending energy crisis and the need to reduce carbon emissions, have led to the development of AI-based ... read more
The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies, is anticipated to o... read more
The recent surge in the demand of radiopharmaceuticals for diagnostic and therapeutic applications, coupled with th... read more
Till date, nearly 150 types of psychedelic therapeutics have been identified and there is a growing body of evidence supporting the ... read more
Given the success of approved repurposed therapeutics, such as Viagra® and Thalomid®, this approach has become a key lifecycle... read more
Over the years, various industry stakeholders have actively invested in the development and implementation of automation technologies for manufacturing operations, in order to min... read more
Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that are capable... read more
Rising demand for viral vectors coupled to lack of scalability and other concerns related to downstream purification, have led stakeholders in this domain to undertake vari... read more
With over 85 microbiome-based, live biotherapeutic products under preclinical and clinical development, the demand f... read more
Given the anticipated increase in demand for vaccines, stakeholders are actively focusing on the development and validation of novel delivery devices, in orde... read more
Reduced manufacturing costs, availability of cheap and skilled labor, coupled to a supportive regulatory landscape has compelle... read more
Proteome profiling is a technically complex and financially demanding field of research; as a result, both pharmaceutical companies and research institutes prefer... read more
Reduced manufacturing costs, availability of cheap and skilled labor and a supportive regulatory landscape in China has comp... read more
Given the success of approved peptide therapeutics, such as Victoza® and Nplate®,  the manufacturing demand has sub... read more
Owing to the numerous complexities associated with clinical research, medical device developers rely on contract service providers in order to reduce the risk... read more
The growing pipeline of therapeutics designed for subcutaneous delivery, coupled to the rising preference for self-medication, is expected to present lucr... read more
Empowered by technical developments in the field of biotechnology and the market opportunity associated with regenerative medicine, a number of research grou... read more
So far, more than 100 different types of cannabinoids have been identified and there is a growing body of evidence supporting the bene... read more
Given the evident immunogenicity, cytotoxicity and high production cost based concerns associated with viral vectors, companies are compelled to... read more
With over 1,000 highly potent drugs in the development pipeline, the demand for developing and manufacturing of such products is an... read more
Traditional drug discovery is associated with exorbitant investments, prolonged lead evolution timelines and high attrition rates; the frag... read more
Compared to batch production methods, continuous manufacturing is not only more time-efficient, but is also associated with reduced energy nee... read more
Increasing awareness related to the importance of reducing carbon footprint across the globe, has compelled individuals to adopt ... read more
The rapidly growing demand for oligonucleotides, coupled to complex manufacturing procedures and high capital investments required for setting u... read more
The success of CTLA4, PD-1, and PD-L1 inhibitors paved the way for researchers to explore the vast therapeutic potential of immune che... read more
The recent approval of first RNAi therapeutic, ONPATTROTM, has caused a surge in interest of the industry / non-industry players in upcoming field of pharmacological resear... read more
Driven by the growing pipeline of injectable drugs, and increasing preference for self-medication, the demand for fill/finish s... read more
Owing to their cost and time saving potential, in silico tools are widely used in modern pharmacological research; several companies have developed ... read more
Outsourcing is presently considered the preferred business model for the development of companion diagnostic tests for personalized therapeu... read more
In order to reduce risk of device recalls and expedite time to market, medical device developers rely on contract servi... read more
The success of approved stem cell therapies has caused a surge in interest of biopharma developers in this field; many innovator companies are currently pr... read more
With multi-billion funding initiatives publicly disclosed by various government agencies, and private investors, various leadin... read more
The genome sequencing domain has witnessed a surge in the availability of service providers, With gene sequencing costs having come down by several ord... read more
With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such pr... read more
The current rate of data generation, coupled to the growing concerns regarding its safety, are anticipated to propel the growth of the colocation da... read more
Increasing demand for energy efficient lighting solutions and growing number of smart city projects across the globe are amongst the key drivers behind th... read more
Rise in prevalence of chronic diseases and the corresponding need to medicate frequently, have led to an increase in demand for safe, self-administrable dosing options. Autoinjectors are conside... read more
Using DNA to develop encoded libraries of pharmacological leads has enabled medical research community to assemble and maintain large ... read more
Prefilled syringes present an attractive packaging option that doubles as an easy-to-use drug delivery device, and a product life cycle management tool. Consequently, they have become indisp... read more
The approval of KYMRIAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell ther... read more
The growing global urgency to reduce carbon footprint, coupled to the long life and low maintenance requirements of lithium ion batteries,... read more
Over time, biopharmaceutical companies have realized the importance of integrating advanced software into the cell and advanced therapies supply chai... read more
Over the years, extensive R&D efforts have established the basis for a wide range of microbiome-based therapeutic and diagnostic product... read more
Given the invasive and cost-intensive nature of tissue biopsies, there is a significant unmet need for safer and more patient-friendly cancer diagnostics ... read more
Over the years, there has been a rise in preference for self-administration of drugs / therapies, resulting in an increasing deman... read more
The recent surge in interest in genetically-modified therapies has resulted in a steep rise in demand for different vectors for fundamental and pharmacological resear... read more
Driven by a robust and growing pipeline of stem cell therapies, the demand for development and manufacturing services for such advanced product candidates is antici... read more
The growing popularity and therapeutic potential of antibody drug conjugates (ADCs) is evident in the rapid growth in intellectual capital, financing... read more
The shift to self-administration of medication, coupled to the need to improve therapy adherence, have driven device developers to design versatile drug delivery devices capable of minimizing ... read more
The success of the approved gene therapies has led to an upward surge in the interest of biopharmaceutical developers in this field, resulting in a significant... read more
Given the recent success of KYMRIAH® and YESCARTA®, the current focus is on establishing a sustainable chimeric antigen receptor T (CAR-T) cell therapy mark... read more
Given the rise in clinical R&D activity focused on gene therapies and other advanced therapy medicinal products, there has been a surge in deman... read more
Owing to the benefits offered in terms of streamlining pharmaceutical filling operations and cutting down on associated costs, pre-sterilized ... read more
Owing to numerous technical and regulatory challenges related to the development and production of medical devices, outsourcing has become a po... read more
Having demonstrated the ability to offer improved treatment related outcomes and also enhance the quality of lives of patients suffering from ... read more
Advances in biotechnology and genome analysis have enabled the identification of several novel cancer biomarkers, which are presently being used for a variety o... read more
The steadily growing demand for vaccines, coupled to the discovery and development of a variety of both preventive and therapeutic vaccine products, has generated a ... read more
Advances in screening technologies have enabled the identification of interactive gene combinations, enabling the development of lead candidates that... read more
Driven by the growing complexity of modern pharmacological interventions, industry stakeholders have turned to more versatile materials for the fabrication of co... read more
Having demonstrated the ability to selectively eradicate tumor cells from the body with minimal treatment-related side effects, T-cell therapies have emerg... read more
Advances in biotechnology and genome analysis have enabled the identification of several novel cancer biomarkers, which are pre... read more
Advances in bioinformatics and genomic data analysis have enabled the identification of cancer antigens that are generally overlooked during immune surveill... read more
Roots Analysis has announced the addition of “Companion Diagnostics Market (2nd Edition), 2019-2030” report to its ... read more
Roots Analysis has announced the addition of “Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030” rep... read more
Roots Analysis has announced the addition of “Next Generation Contact Lenses and Visual Prostheses Market, 2019-2030” report to its list of offerings.&nbs... read more
Roots Analysis has announced the addition of “Extractables and Leachables Testing Services Market, 2018-2028” report to it... read more
Roots Analysis has announced the addition of “Medical Device CROs Market, 2018-2030” report to its list of offerings. Shifali Gupta, the principal analyst, stated, “Give... read more
Roots Analysis has announced the addition of “Cell Therapy Manufacturing Market (2nd Edition), 2018-2030” report to its list of offerings. Natasha Thakur, the principal analyst, stated, &ldq... read more
Roots Analysis has announced the addition of “Blockchain in Genomic Data Management: Market Landscape and Competitive Insights, 2018-2030” report to its list o... read more
Roots Analysis has announced the addition of “Real World Evidence: Market Landscape and Competitive Insights, 2018-2030” report to its list ... read more
Roots Analysis has announced the addition of “Antibody Discovery: Services and Platforms Market (2nd Edition), 2018-2028” report to i... read more
Roots Analysis has announced the addition of “Cell Therapy Manufacturing Market (2nd Edition), 2018-2030” report to its list of offerings. Natasha Thakur, the principal ana... read more
Roots Analysis has announced the addition of “Computer-Aided Drug Discovery Services Market, 2018-2030” report to its list of offerings. Akash Mishra, the principal analy... read more
Roots Analysis has announced the addition of “Viral Vectors and Plasmid DNA Manufacturing Market (2nd Edition), 20... read more
Roots Analysis has announced the release of its “T-Cell Immunotherapy Market (3rd Edition), 2018-2030”report. Pemba Lahmo, the principal analyst, stated, “With two approved th... read more
Roots Analysis has announced the addition of “Back of the Eye Disorders: Novel Drugs and Delivery Technologies, 2017-2030” report to its list of offerings... read more
Roots Analysis announced the addition of “Novel Drugs and Smart Devices for Respiratory Disorders, 2018-2030” report to its list of offerings. Roh... read more
Roots Analysis has announced the addition of 3D Bioprinting: Technologies, Products and Key Application Areas, (2nd Edition), 2018-2035’ report to its list of offerings. The report provides a comprehensive analysis of the current landsc... read more
Roots Analysis has announced the addition of ‘Antibody Drug Conjugates Market (4th Edition), 2017-2030’ report to their list of offerings. The report features an extensive study on current landscape and the future out... read more
Roots Analysis has announced the addition of “Modular Facilities in Pharmaceutical / Biotechnology Industry, 2017-2030”report to their list of offerings. The report features an extensive study on current landscape ... read more
Roots Analysis has announced the addition of “Cell Line Development Services Market, 2017-2027” report to its list of offerings. The report features an extensive study on the rapidly growing market of c... read more
Roots Analysis has announced the addition of “Antibody Discovery: Services and Platforms, 2017-2027” report to its list of offerings. The report features an extensive study on the current market l... read more
Roots Analysis has announced the addition of the “Rheumatoid Arthritis: Beyond TNF Inhibitors, 2016-2026” report to its list of offerings. The report provides a comprehensive analysis of the current market landscape of therapies for the treat... read more
Roots Analysis has announced the addition of “Global Non-Invasive Prenatal Testing and Newborn Screening Market, 2017-2030” report to its list of offerings. The report p... read more
Roots Analysis has announced the addition of “Biopharmaceutical Contract Manufacturing Market (2nd Edition), 2017 - 2027” report to its list of offerings. The report provides an extensive study of the contract man... read more
Roots Analysis has announced the addition of “Non-Invasive Cancer Diagnostics Market (2nd Edition), 2017-2030” report to its list of offerings. The report provides a comprehensive analysis of the current landscape and future outl... read more
Roots Analysis has announced the addition of “Deep Learning in Drug Discovery and Diagnostics, 2017-2035” report to its list of offerings. The report provides a comprehens... read more
Roots Analysis has announced the addition of “Cell Therapy Manufacturing Market, 2017-2027” report to its list of offerings. The report provides an extensive study on the current landscape of the rapidly growing mark... read more
Roots Analysis has announced the addition of “Antibacterial Drug Resistance: Market Landscape, Challenges and Upcoming Opportunities, 2016-2026” report to its portfolio. The report provides a... read more
Roots Analysis has announced the addition of the “T-Cell Immunotherapy Market, 2017-2030 (2nd edition)” report to its portfolio. The report features an extensive study of the current market lands... read more
Roots Analysis has announced the addition of the “Prefilled Syringes Market (4th Edition), 2017-2026” report to its list of offerings. The report provides a comprehensive analysis of the current state and ... read more
Roots Analysis has announced the addition of the “Viral Vectors and Plasmid DNA Manufacturing Market, 2016-2026” report to its portfolio. The report features an extensive study of the rapi... read more
Roots Analysis has announced the addition of the “Smart Wearables in Healthcare, 2016-2030” report to its list of offerings. The report provides a comprehensive analysis of the current market landscape with respect to key players a... read more
Roots Analysis has announced the addition of the “HDAC Inhibitors Market, 2016-2026” report to their list of offerings. It provides a comprehensive study on the current landscape of the evolving pipeline in ... read more
Roots Analysis has announced the addition of the “Novel Drugs and Devices to Lower Intraocular Pressure, 2016 - 2026” report to its list of offerings. The report provides a deta... read more
Roots Analysis has announced the addition of “Non-Insulin Therapies for Diabetes: GLP-1 Agonists, DPP4 Inhibitors and SGLT2 Inhibitors, 2016 - 2026” report to its portfolio. The report provides a comprehensive analys... read more
Roots Analysis has announced the addition of the “Vaccine Contract Manufacturing Market, 2016-2026” report to its list of offerings. The report provides an extensive study of the current market lan... read more
Roots Analysis has announced the addition of “Global Autoinjectors Market, 2016-2026” report to its portfolio. The report provides a comprehensive analysis of the current state of autoinjectors market and the lik... read more
Roots Analysis has announced the addition of HPAPIs and Cytotoxic Drugs Manufacturing Market, 2016-2026 (2nd edition)  report to its portfolio. The report provides an extensive study of the contract ... read more
Roots Analysis has announced the addition of Specialty CROs Market, 2016-2025 report to their offering. The report delivers a comprehensive study on Contract Research Organizations (CROs) that offer specialized sets of research capabilities/s... read more
Roots Analysis has announced the addition of “Peptide Therapeutics in Metabolic Disorders, 2016-2025” report to its portfolio. The report provides a comprehensive study on the current market landscape and the future outlook... read more
Roots Analysis has announced the addition of “Microbiome Therapeutics Market, 2015-2030” report to their offering. The report provides a comprehensive study on the current landscape and the future outlook of the evolving pi... read more
Roots Analysis has announced the addition of “RNAi Therapeutics Market, 2015-2030” report to their offering. The study offers a comprehensive analysis of the current landscape and future outlook of t... read more
Roots Analysis has announced the addition of “Non-invasive Cancer Diagnostics Market, 2015-2030” report to their offering. The report offers an extensive study of several commercialized and / or under development non-invasive diag... read more
After the early success of Immune Checkpoint Inhibitors, T-cell immunotherapy has emerged as another innovative and potent arm of the immuno-oncology market. Characterised by key features such as target specifi... read more
Roots Analysis has announced the addition of “NASH Drugs Market, 2015-2025” report to their offering. The study offers a comprehensive analysis of the current landscape and future outlook of the evolving pipeline ... read more
Roots Analysis has announced the addition of “Immune Checkpoint Inhibitors Market (2nd edition), 2015-2025” report to its portfolio. The study provides a comprehensive analysis of the current market landscape and fu... read more
Roots Analysis has announced the addition of “3D Culture Market, 2015-2025” report to their offering. The 3D culture approach is emerging as a promising tool that surmounts the limitations posed by monolayer or 2D culture syste... read more
Roots Analysis has announced the addition of “Sustained Release Ocular Drug Delivery Systems Market, 2015-2025 (2nd edition)” report to their offering. The report provides an extensive study of the emerging marke... read more
Roots Analysis has announced the addition of “BBB Technologies: Novel CNS Drug Delivery Approaches, 2015 - 2030” report to its portfolio.  The report provides an extensive study of the emerging market of BBB... read more
Roots Analysis has announced the addition of ‘Biopharmaceutical Contract Manufacturing Market, 2015-2025’ report to their offering. The report provides an extensive study of the contract manufacturing opportunity for this ... read more
Roots Analysis has announced the addition of “Non-Tyrosine Kinase Inhibitors in Oncology, 2015-2025” report to their offering.  The report provides a comprehensive analysis of the curren... read more
Roots Analysis has announced the addition of “Gene Therapy Market, 2015-2025” report to their offering. The market currently has only five approved therapies; of these, four are commercialised in geogr... read more
Roots Analysis has announced the addition of “Rare Diseases: The Pharmaceutical Landscape and Opportunity Areas” report to its portfolio. The report provides a comprehensive study of the pipeline drugs being developed fo... read more
Roots Analysis has announced the addition of “Immune Checkpoint Inhibitors Market, 2014-2024” report to their offering. The study offers a comprehensive view of the emerging market of CTLA-4... read more
Roots Analysis has announced the addition of “Needlestick Safety Injection Devices, 2014 - 2024” report to their offering. The study offers a comprehensive view of the product portfolio of safety injection devices, their compara... read more
Roots Analysis has announced the addition of “Large Volume Wearable Injectors, 2014-2025” report to its portfolio. The report is the second edition of the original publication titled “Bolus Injectors, 2014-2024” re... read more
Roots Analysis has announced the addition of “Glycated Haemoglobin (HbA1c) Testing Market, 2014 - 2024” report to its portfolio.  The report provides an extensive study of the growing market for HbA1c t... read more
Roots Analysis has announced the addition of “HPAPIs and Cytotoxic Drugs Manufacturing Market” report to their portfolio.  The report provides an extensive study of the contract manufact... read more
Roots Analysis has just released the 2nd edition of its publication "Prefilled Syringes Market, 2014 - 2024 (2nd edition)", acomprehensive study on the product pipeline, technological progr... read more
Roots Analysis has announced the addition of “Companion Diagnostics Market, 2014 - 2024 (2nd edition)” report to their offering. The study offers an extensive analysis of this growing marke... read more
Roots Analysis has announced the addition of “Sustained Release Ocular Drug Delivery Systems Market, 2014-2024” report to their offering. The report provides an extensive study of this field, focusing on commerc... read more
Roots Analysis has announced the addition of the “Single-use Bioreactors, 2014-2024” report to their offering. The report provides an extensive study of this emerging field, including detailed sales forecast of single-use bioreactors in the... read more
Roots Analysis has announced addition of the “Antibody Drug Conjugates: Contract Manufacturing Market, 2014-2024” report to their offering. The report provides an extensive stud... read more
A new report published by Roots Analysis provides a comprehensive view of the emerging market of “Oral Proteins and Peptides”. Apart from profiling the various drugs which are in different stages of clinical trials, the study also talks about many... read more
Roots Analysis latest publication on “Bolus Injectors” predicts that the market for these devices is likely to be ~USD 8.8 billion by 2024. Also known as ‘patch pumps’ and ‘large volume injectors’, the first c... read more
Roots Analysis has announced addition of the “Bispecific Antibody Therapeutics Market, 2013-2023” report to their offering. The report provides an extensive study of this emerging field, including... read more
Roots Analysis has announced addition of the “Fc Protein and Glycoengineered Antibodies Market, 2013-2023” report to their offering. The report provides an extensive study of this emerging field, including detailed s... read more
A new report published by Roots Analysis Private Limited estimates the market for Antibody Drug Conjugates (ADCs) to grow to USD 9 billion annually by 2023. The report provides an extensive study of this em... read more
A new report published by Roots Analysis Private Ltd. forecasts the market for prefilled syringe systems to grow at a CAGR of 13.8% during the forecast period 2012-2018. According to the report titled ‘Prefilled Syringes Wor... read more
A new report published by Roots Analysis Private Ltd., a research group focused solely in the pharmaceutical industry, estimates that Companion Diagnostics market was worth USD 193 MM in 2012. This represented 10.1% of the total Personali... read more
A new report released by Roots Analysis Private Ltd. forecasts the market for Alzheimer’s drugs to grow at a CAGR of 8.0% during the period 2012-2017. According to the report titled ‘Alzheimer’s Drugs Market, 2012-2017... read more

MEDIA CITATIONS

  • We are your partners with no equity

  • We fit in your budget

  • We love what we do

  • Chance to prove ourselves

  • Best in class quality of work

  • Most trusted consulting partner in the industry